Soluble p2x7 receptor is elevated in the plasma of covid-19 patients and correlates with disease severity

HIGHLIGHTS

• who: Julio Garcí from the Research Institute of Murcia (IMIB-Arrixaca), University Clinical Hospital Virgen Arrixaca, Murcia, Spain have published the research work: Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity, in the Journal: (JOURNAL)
• what: The authors show that human peripheral blood mononuclear cells release the P2X7 receptor when treated with ATP. The study shows that the soluble P2X7 receptor concentration increases in the plasma of COVID-19 and positively correlates with disease severity and CRP protein concentration. MATERIAL AND METHODS Human Samples Samples . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.